Biotech: Page 35

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Alex AZAR Maria CROWE Dave RICKS Lilly Makes Management Changes Lilly has announced a number of key management appointments. Alex Azar has been promoted to president of Lilly USA, the company’s...

    By Carolyn Gretton • Dec. 22, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New electronic and web-based applications, sites, and technologies By Carolyn Gretton ImpactRx Adds Tablet Detailing to Analytics Offerings Trend: Growing physician adoption of tablet computers is prompting pharma brand teams to design and execute messaging strategies that more effectively employ...

    By Carolyn Gretton • Dec. 22, 2011
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Pharma Turning to Health Outcomes Liaison Teams Trend: Trailblazing pharma companies are assembling elite health outcomes liaison (HOL) teams ­focused on market access priorities and supporting these groups ...

    By Carolyn Gretton • Dec. 22, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Building a Culture of Innovation

    Pharmaceutical R&D is under pressure to counter rising costs, depleted pipelines, and impending patent expiries. The industry is facing not only a productivity crisis, but also a crisis in innovation. Industry analysts say many pharmaceutical and biopharma companies are turning their focus aw...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    C-Suite: Executive Insights

    CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the coming years. Jed Be...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's Ahead for 2012

    Our readers identified the top trends and game changers they expect to define the various industry sectors in the coming year. John Blakeley Executive VP and Chief Commercial Officer ERT, a clinical research service provider that assesses the safety of newly developed drugs by major pharmaceutica...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Year of the Extreme Makeover

    Every sector in the industry is in a state of flux. In this special issue of PharmaVOICE, more than 160 thought leaders throughout the life-sciences industry discuss the changing market dynamics. According to PricewaterhouseCooper’s 14th Annual Global CEO Survey, which looks at the concerns expre...

    By Denise Myshko and Robin Robinsons • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Percival BARRETTO-KO Astellas Realigns Executive Team Astellas US, the U.S. affiliate of Tokyo-based Astellas Pharma, has named Percival Barretto-Ko senior VP, corporate strategy and government affairs. Mr. Barretto-Ko was previously executive director, corporate strategy and ...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New healthcare-related products, services, and companies Grey Group Launches Grey Healthy People Trend: Delivering cross-platform, integrated marketing solutions across a broad spectrum of health, wellness, and lifestyle sectors ­continues to be a driving force within agencies. Grey Healthy Peopl...

    By Carolyn Gretton • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Attendees interested in maximizing their clinical trial performance by bridging the gap between identifying and implementing metrics, learning about best practices on processing data and on-site performance to improve...

    By PharmaVoice Team • Nov. 11, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Is the Business of Health Care Getting in the Way of Providing Good Health Care?

    “It’s not my job to sell your treatment." This was a profound statement I heard a few years ago from a physician during market research. Today, I think I would hear something significantly more threatening: “I can’t afford to use your treatment." In the last few years, thousands of smaller practi...

    By Ken Ribotsky • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hello South Africa

    A Diverse and Sophisticated Market With a diverse population, a thriving research environment, strong infrastructure along with geographic reach into the rest of Africa, South Africa has many advantages for the global pharma industry. With its population of more than 50 million people from divers...

    By Kim Ribbink • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    New Science Means New Ways to Target Disease

    Epigenetics — the study of changes in gene expression — is ­rapidly ­emerging as a field that presents tremendous opportunity for drug discovery. We are on the edge of a new biology. It turns out that our genes are just part of the story about what makes us who we are. Much has been learned over ...

    By Denise Myshko • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Changing Market Environment Requires New PLM Strategies

    In a market environment that is increasingly value-based, the industry must begin to review its product life-cycle management (PLM) strategy and prepare for more effective ways to cope with the evolving challenges when it comes to pipeline maintenance. For example, companies need to start impleme...

    By Robin Robinson • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Taking Innovation to a New Level Ulrich Betz, Ph.D., Director at Merck Serono Portfolio Development and Head of the Department Center of Innovation, talks about fostering innovation and entrepreneurial thinking within the company. PV: What is the Merck Serono internal Innospire innovation program...

    By Ulrich Betz • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Greg IRACE Anne WHITAKER Sanofi Shifts U.S. Leadership Sanofi has named Greg Irace senior VP, global services. Mr. Irace leads the global information systems function and is responsible for shared support functions across all Sanofi businesses in North America. He also plays a...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New electronic and web-based applications, sites, and technologies POR Provides Real-Time Engagement Between Doctors and Brands Trend: Driven by physician access issues and shrinking sales forces, pharma brand marketers are looking for ways to use nonpersonal and digital promotion more effectivel...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Awards… » Agile Recognized by New Jersey Group Agile Therapeutics has been named Life Sciences Company of the Year by the New Jersey Technology Council, a nonprofit ­organization supporting growth in N.J.’s various technology ­sectors, including health sciences. » Ogilvy Wins Spanish Awards Ogilv...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Letter from the Editor Nurturing the Life Cycle The challenges facing the industry — declining R&D productivity, a changing healthcare landscape, and increasing competition from generics, among others — have been well-publicized. In the past, cost-cutting measures, outcomes, and trial managem...

    By Taren Grom • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Decoding Data Dynamics

    By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being...

    By Carolyn Gretton • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hola Mexico: Pharma Drawn to U.S. Neighbor

    By Kim Ribbin Growing health coverage, high medical standards, a ­motivated patient population, and huge geographic ­advantages make Mexico an appealing market for the ­pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...

    By Kim Ribbink • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Beyond Stem Cells

    By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, recei...

    By Denise Myshko • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Mentoring: More Crucial Than Ever

    By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentorin...

    By Robin Robinson • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Making Strategic Alliances Work Wa’el Hashad, VP, U.S. Cardiovascular and Metabolic Disorders, at Boehringer Ingelheim Pharmaceuticals, talks about how an alliance with Lilly helped to bring a new product to the diabetes market. PV: What challenges are encountered when ­developing diabetes produc...

    By PharmaVoice Team • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Tomas BOCANEGRA Pozen Appoints Development VP Pozen, a pharmaceutical company committed to developing medicines that transform lives, has named Tomas Bocanegra, M.D., executive VP of develo...

    By PharmaVoice Team • Aug. 29, 2011